| Introduction |
|
1 | (4) |
| Part 1: Historical Signs |
|
5 | (116) |
|
1.1 General, systemic and metabolic historical signs |
|
|
5 | (17) |
|
1.1.1 Polyuria/polydipsia |
|
|
5 | (2) |
|
|
|
7 | (2) |
|
|
|
9 | (1) |
|
|
|
10 | (1) |
|
1.1.5 Anorexia/inappetence |
|
|
11 | (2) |
|
|
|
13 | (1) |
|
|
|
14 | (4) |
|
|
|
18 | (4) |
|
1.2 Gastrointestinal/abdominal historical signs |
|
|
22 | (29) |
|
1.2.1 Ptyalism/salivation/hypersalivation |
|
|
22 | (2) |
|
|
|
24 | (2) |
|
|
|
26 | (1) |
|
|
|
27 | (1) |
|
|
|
28 | (6) |
|
|
|
34 | (6) |
|
|
|
40 | (2) |
|
|
|
42 | (2) |
|
|
|
44 | (2) |
|
1.2.10 Constipation/obstipation |
|
|
46 | (2) |
|
1.2.11 Faecal tenesmus/dyschezia |
|
|
48 | (1) |
|
1.2.12 Faecal incontinence |
|
|
49 | (1) |
|
1.2.13 Flatulence/borborygmus |
|
|
50 | (1) |
|
1.3 Cardiorespiratory historical signs |
|
|
51 | (8) |
|
|
|
51 | (1) |
|
1.3.2 Dyspnoea/tachypnoea |
|
|
52 | (1) |
|
1.3.3 Sneezing and nasal discharge |
|
|
53 | (2) |
|
|
|
55 | (1) |
|
|
|
56 | (2) |
|
1.3.6 Exercise intolerance |
|
|
58 | (1) |
|
1.4 Dermatological historical signs |
|
|
59 | (2) |
|
|
|
59 | (2) |
|
1.5 Neurological historical signs |
|
|
61 | (29) |
|
|
|
61 | (4) |
|
1.5.2 Trembling/shivering |
|
|
65 | (2) |
|
|
|
67 | (9) |
|
|
|
76 | (4) |
|
|
|
80 | (2) |
|
1.5.6 Altered behaviour: General changes |
|
|
82 | (2) |
|
1.5.7 Altered behaviour: Specific behavioural problems |
|
|
84 | (1) |
|
|
|
85 | (2) |
|
1.5.9 Multifocal neurological disease |
|
|
87 | (3) |
|
1.6 Ocular historical signs |
|
|
90 | (5) |
|
1.6.1 Blindness/visual impairment |
|
|
90 | (3) |
|
1.6.2 Epiphora/tear overflow |
|
|
93 | (2) |
|
1.7 Musculoskeletal historical signs |
|
|
95 | (9) |
|
|
|
95 | (4) |
|
|
|
99 | (4) |
|
1.7.3 Multiple joint/limb lameness |
|
|
103 | (1) |
|
1.8 Reproductive historical signs |
|
|
104 | (11) |
|
1.8.1 Failure to observe oestrus |
|
|
104 | (2) |
|
|
|
106 | (1) |
|
1.8.3 Infertility in the female with normal oestrus |
|
|
107 | (1) |
|
|
|
108 | (3) |
|
1.8.5 Vaginal/vulval discharge |
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
112 | (2) |
|
|
|
114 | (1) |
|
1.9 Urological historical signs |
|
|
115 | (6) |
|
1.9.1 Pollakiuria/dysuria/stranguria |
|
|
115 | (1) |
|
1.9.2 Polyuria/polydipsia |
|
|
115 | (1) |
|
|
|
116 | (1) |
|
|
|
117 | (2) |
|
1.9.5 Urinary incontinence/inappropriate urination |
|
|
119 | (2) |
| Part 2: Physical Signs |
|
121 | (92) |
|
2.1 General/miscellaneous physical signs |
|
|
121 | (14) |
|
2.1.1 Abnormalities of body temperature - hyperthermia |
|
|
121 | (6) |
|
2.1.2 Abnormalities of body temperature - hypothermia |
|
|
127 | (1) |
|
2.1.3 Enlarged lymph nodes |
|
|
127 | (3) |
|
|
|
130 | (1) |
|
|
|
130 | (2) |
|
|
|
132 | (1) |
|
|
|
133 | (2) |
|
2.2 Gastrointestinal/abdominal physical signs |
|
|
135 | (11) |
|
|
|
135 | (2) |
|
2.2.2 Abdominal distension |
|
|
137 | (1) |
|
|
|
138 | (3) |
|
|
|
141 | (1) |
|
|
|
142 | (2) |
|
2.2.6 Abnormal liver palpation |
|
|
144 | (2) |
|
2.3 Cardiorespiratory physical signs |
|
|
146 | (18) |
|
2.3.1 Dyspnoea/tachypnoea |
|
|
146 | (5) |
|
|
|
151 | (1) |
|
|
|
151 | (2) |
|
|
|
153 | (2) |
|
|
|
155 | (1) |
|
2.3.6 Abnormal respiratory sounds |
|
|
155 | (1) |
|
2.3.7 Abnormal heart sounds |
|
|
156 | (4) |
|
2.3.8 Abnormalities in heart rate |
|
|
160 | (3) |
|
2.3.9 Jugular distension/hepatojugular reflux |
|
|
163 | (1) |
|
2.3.10 Alterations in arterial pulse |
|
|
163 | (1) |
|
|
|
164 | (19) |
|
|
|
164 | (2) |
|
2.4.2 Pustules and papules (including miliary dermatitis) |
|
|
166 | (2) |
|
|
|
168 | (2) |
|
2.4.4 Pigmentation disorders (coat or skin) |
|
|
170 | (2) |
|
|
|
172 | (2) |
|
2.4.6 Erosive/ulcerative skin disease |
|
|
174 | (2) |
|
|
|
176 | (2) |
|
|
|
178 | (2) |
|
2.4.9 Disorders of the claws |
|
|
180 | (2) |
|
2.4.10 Anal sac/perianal disease |
|
|
182 | (1) |
|
|
|
183 | (9) |
|
2.5.1 Abnormal cranial nerve (CN) responses |
|
|
183 | (3) |
|
|
|
186 | (3) |
|
|
|
189 | (1) |
|
2.5.4 Hemineglect syndrome (Forebrain dysfunction q.v.) |
|
|
190 | (1) |
|
|
|
190 | (2) |
|
|
|
192 | (12) |
|
|
|
192 | (5) |
|
2.6.2 Corneal opacification |
|
|
197 | (1) |
|
2.6.3 Corneal ulceration/erosion |
|
|
198 | (2) |
|
|
|
200 | (1) |
|
|
|
201 | (2) |
|
2.6.6 Intraocular haemorrhage/hyphaema |
|
|
203 | (1) |
|
2.6.7 Abnormal appearance of anterior chamber |
|
|
204 | (1) |
|
2.7 Musculoskeletal signs |
|
|
204 | (3) |
|
2.7.1 Muscular atrophy or hypertrophy |
|
|
204 | (2) |
|
2.7.2 Trismus ('lockjaw') |
|
|
206 | (1) |
|
|
|
207 | (1) |
|
2.8 Urogenital physical signs |
|
|
207 | (6) |
|
2.8.1 Kidneys abnormal on palpation |
|
|
207 | (1) |
|
2.8.2 Bladder abnormalities |
|
|
208 | (2) |
|
2.8.3 Prostate abnormal on palpation |
|
|
210 | (1) |
|
2.8.4 Uterus abnormal on palpation |
|
|
210 | (1) |
|
2.8.5 Testicular abnormalities |
|
|
211 | (1) |
|
2.8.6 Penis abnormalities |
|
|
211 | (2) |
| Part 3: Radiographic and Ultrasonographic Signs |
|
213 | (100) |
|
|
|
213 | (24) |
|
3.1.1 Artefactual causes of increased lung opacity |
|
|
213 | (1) |
|
3.1.2 Increased bronchial pattern |
|
|
213 | (1) |
|
3.1.3 Increased alveolar pattern |
|
|
214 | (3) |
|
3.1.4 Increased interstitial pattern |
|
|
217 | (3) |
|
3.1.5 Increased vascular pattern |
|
|
220 | (1) |
|
3.1.6 Decreased vascular pattern |
|
|
221 | (1) |
|
3.1.7 Cardiac diseases that may be associated with a normal cardiac silhouette |
|
|
222 | (1) |
|
3.1.8 Increased size of cardiac silhouette |
|
|
222 | (1) |
|
3.1.9 Decreased size of cardiac silhouette |
|
|
223 | (1) |
|
3.1.10 Abnormalities of the ribs |
|
|
224 | (1) |
|
3.1.11 Abnormalities of the oesophagus |
|
|
225 | (3) |
|
3.1.12 Abnormalities of the trachea |
|
|
228 | (2) |
|
|
|
230 | (2) |
|
|
|
232 | (1) |
|
3.1.15 Abnormalities of the diaphragm |
|
|
233 | (1) |
|
3.1.16 Mediastinal abnormalities |
|
|
234 | (3) |
|
3.2 Abdominal radiography |
|
|
237 | (27) |
|
|
|
237 | (2) |
|
|
|
239 | (2) |
|
|
|
241 | (3) |
|
|
|
244 | (7) |
|
|
|
251 | (1) |
|
|
|
251 | (3) |
|
|
|
254 | (1) |
|
|
|
255 | (3) |
|
3.2.9 Loss of intra-abdominal contrast |
|
|
258 | (2) |
|
|
|
260 | (1) |
|
|
|
261 | (1) |
|
|
|
261 | (1) |
|
3.2.13 Abdominal calcification/mineral density |
|
|
262 | (2) |
|
|
|
264 | (11) |
|
|
|
264 | (1) |
|
3.3.2 Altered shape of the long bones |
|
|
264 | (1) |
|
|
|
265 | (1) |
|
3.3.4 Delayed ossification/growth plate closure |
|
|
266 | (1) |
|
3.3.5 Increased radiopacity |
|
|
266 | (1) |
|
3.3.6 Periosteal reactions |
|
|
267 | (1) |
|
|
|
267 | (1) |
|
|
|
268 | (2) |
|
|
|
270 | (1) |
|
3.3.10 Mixed osteolytic/osteogenic lesions |
|
|
271 | (1) |
|
|
|
271 | (4) |
|
3.4 Radiography of the head and neck |
|
|
275 | (7) |
|
3.4.1 Increased radiopacity/bony proliferation a of the maxilla |
|
|
275 | (1) |
|
3.4.2 Decreased radiopacity of the maxilla |
|
|
275 | (1) |
|
3.4.3 Increased radiopacity/bony proliferation of the mandible |
|
|
276 | (1) |
|
3.4.4 Decreased radiopacity of the mandible |
|
|
276 | (1) |
|
3.4.5 Increased radiopacity of the tympanic bulla |
|
|
276 | (1) |
|
3.4.6 Decreased radiopacity of the nasal cavity |
|
|
277 | (1) |
|
3.4.7 Increased radiopacity of the nasal cavity |
|
|
277 | (2) |
|
3.4.8 Increased radiopacity of the frontal sinuses |
|
|
279 | (1) |
|
3.4.9 Increased radiopacity of the pharynx |
|
|
279 | (1) |
|
3.4.10 Thickening of the soft tissues of the head and neck |
|
|
280 | (1) |
|
3.4.11 Decreased radiopacity of the soft tissues of the head and neck |
|
|
281 | (1) |
|
3.4.12 Increased radiopacity of the soft tissues of the head and neck |
|
|
281 | (1) |
|
3.5 Radiography of the spine |
|
|
282 | (7) |
|
3.5.1 Normal and congenital variation in vertebral shape and size |
|
|
282 | (1) |
|
3.5.2 Acquired variation in vertebral shape and size |
|
|
283 | (2) |
|
3.5.3 Changes in vertebral radiopacity |
|
|
285 | (1) |
|
3.5.4 Abnormalities in the intervertebral space |
|
|
286 | (1) |
|
3.5.5 Contrast radiography of the spine (myelography) |
|
|
287 | (2) |
|
3.6 Thoracic ultrasonography |
|
|
289 | (5) |
|
|
|
289 | (1) |
|
|
|
290 | (1) |
|
3.6.3 Pericardial effusion |
|
|
290 | (1) |
|
3.6.4 Altered chamber dimensions |
|
|
291 | (3) |
|
3.6.5 Changes in ejection phase indices of left ventricular performance (fractional shortening, FS%; ejection fraction, EF) |
|
|
294 | (1) |
|
3.7 Abdominal ultrasonography |
|
|
294 | (14) |
|
|
|
294 | (3) |
|
3.7.2 Hepatobiliary disease |
|
|
297 | (3) |
|
|
|
300 | (1) |
|
|
|
301 | (1) |
|
|
|
302 | (1) |
|
3.7.6 Urinary bladder disease |
|
|
302 | (2) |
|
3.7.7 Gastrointestinal disease |
|
|
304 | (1) |
|
3.7.8 Ovarian and uterine disease |
|
|
305 | (1) |
|
|
|
306 | (1) |
|
|
|
306 | (2) |
|
3.8 Ultrasonography of other regions |
|
|
308 | (5) |
|
|
|
308 | (1) |
|
|
|
309 | (2) |
|
|
|
311 | (2) |
| Part 4: Laboratory Findings |
|
313 | (97) |
|
|
|
313 | (29) |
|
|
|
313 | (2) |
|
4.1.2 Alanine transferase |
|
|
315 | (1) |
|
4.1.3 Alkaline phosphatase |
|
|
316 | (2) |
|
|
|
318 | (1) |
|
|
|
319 | (1) |
|
4.1.6 Aspartate aminotransferase |
|
|
320 | (1) |
|
|
|
321 | (1) |
|
4.1.8 Bile acids/dynamic bile acid test |
|
|
322 | (1) |
|
4.1.9 C-reactive protein (D) |
|
|
322 | (1) |
|
|
|
323 | (1) |
|
|
|
324 | (1) |
|
|
|
324 | (1) |
|
|
|
325 | (1) |
|
|
|
326 | (1) |
|
|
|
326 | (1) |
|
|
|
327 | (1) |
|
4.1.17 Gamma-glutamyl transferase |
|
|
327 | (1) |
|
|
|
328 | (1) |
|
|
|
329 | (1) |
|
|
|
330 | (3) |
|
|
|
333 | (1) |
|
4.1.22 Lactate dehydrogenase |
|
|
333 | (2) |
|
|
|
335 | (1) |
|
|
|
336 | (1) |
|
|
|
337 | (1) |
|
4.1.26 Trypsin-like immunoreactivity |
|
|
338 | (1) |
|
|
|
338 | (3) |
|
4.1.28 Vitamin B12 (cobalamin) |
|
|
341 | (1) |
|
|
|
341 | (1) |
|
4.2 Haematological findings |
|
|
342 | (23) |
|
4.2.1 Regenerative anaemia |
|
|
342 | (3) |
|
4.2.2 Poorly/non-regenerative anaemia |
|
|
345 | (3) |
|
|
|
348 | (2) |
|
|
|
350 | (3) |
|
|
|
353 | (1) |
|
|
|
354 | (1) |
|
|
|
355 | (2) |
|
|
|
357 | (1) |
|
|
|
358 | (1) |
|
|
|
359 | (1) |
|
|
|
360 | (1) |
|
|
|
361 | (1) |
|
|
|
361 | (1) |
|
|
|
362 | (1) |
|
4.2.15 Increased buccal mucosal bleeding time (disorders of primary haemostasis) |
|
|
362 | (1) |
|
4.2.16 Increased prothrombin time (disorders of extrinsic and common pathways) |
|
|
363 | (1) |
|
4.2.17 Increased partial thromboplastin time or activated clotting time (disorders of intrinsic and common pathways) |
|
|
363 | (1) |
|
4.2.18 Increased fibrin degradation products |
|
|
364 | (1) |
|
4.2.19 Decreased fibrinogen levels |
|
|
364 | (1) |
|
4.2.20 Decreased antithrombin III levels |
|
|
364 | (1) |
|
4.3 Electrolyte and blood gas findings |
|
|
365 | (16) |
|
|
|
365 | (2) |
|
|
|
367 | (2) |
|
|
|
369 | (2) |
|
|
|
371 | (2) |
|
|
|
373 | (2) |
|
|
|
375 | (2) |
|
|
|
377 | (2) |
|
|
|
379 | (2) |
|
|
|
381 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (11) |
|
4.4.1 Alterations in specific gravity |
|
|
381 | (2) |
|
4.4.2 Abnormalities in urine chemistry |
|
|
383 | (5) |
|
4.4.3 Abnormalities in urine sediment |
|
|
388 | (2) |
|
|
|
390 | (2) |
|
|
|
392 | (9) |
|
4.5.1 Tracheal/bronchoalveolar lavage |
|
|
392 | (2) |
|
4.5.2 Nasal flush cytology |
|
|
394 | (1) |
|
|
|
395 | (2) |
|
|
|
397 | (1) |
|
4.5.5 Skin scrapes/hair plucks/tape impressions |
|
|
398 | (1) |
|
4.5.6 Cerebrospinal fluid (CSF) analysis |
|
|
398 | (2) |
|
4.5.7 Fine-needle aspiration of cutaneous/subcutaneous masses |
|
|
400 | (1) |
|
4.6 Hormones/endocrine testing |
|
|
401 | (7) |
|
|
|
401 | (2) |
|
4.6.2 Parathyroid hormone |
|
|
403 | (1) |
|
4.6.3 Cortisol (baseline or post-ACTH stimulation test) |
|
|
404 | (1) |
|
|
|
405 | (1) |
|
|
|
405 | (1) |
|
4.6.6 Vitamin D (1,25-dihydroxycholecalciferol) |
|
|
405 | (1) |
|
|
|
406 | (1) |
|
|
|
406 | (1) |
|
|
|
407 | (1) |
|
|
|
407 | (1) |
|
4.7 Faecal analysis findings |
|
|
408 | (2) |
|
|
|
408 | (1) |
|
|
|
408 | (1) |
|
|
|
409 | (1) |
|
4.7.4 Faecal fungal infections |
|
|
409 | (1) |
|
4.7.5 Undigested food residues |
|
|
409 | (1) |
| Part 5: Electrodiagnostic Testing |
|
410 | (14) |
|
5.1 Electrocardiographic findings |
|
|
410 | (12) |
|
5.1.1 Alterations in P wave |
|
|
410 | (1) |
|
5.1.2 Alterations in QRS complex |
|
|
411 | (2) |
|
5.1.3 Alterations in P-R relationship |
|
|
413 | (1) |
|
5.1.4 Alterations in S-T segment |
|
|
414 | (1) |
|
5.1.5 Alterations in Q-T interval |
|
|
415 | (1) |
|
5.1.6 Alterations in T wave |
|
|
416 | (1) |
|
5.1.7 Alterations in baseline |
|
|
416 | (1) |
|
|
|
416 | (4) |
|
5.1.9 Alterations in rate |
|
|
420 | (2) |
|
5.2 Electromyographic findings |
|
|
422 | (1) |
|
5.2.1 Spontaneous activity |
|
|
422 | (1) |
|
|
|
423 | (1) |
|
5.3 Nerve conduction velocity findings |
|
|
423 | (1) |
|
|
|
423 | (1) |
|
|
|
423 | (1) |
| Index |
|
424 | |